These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 17131173)
1. Low levels of plasma soluble complement receptor type 1 in patients receiving thrombolytic therapy for acute myocardial infarction. Karthikeyan G; Baalasubramanian S; Seth S; Das N J Thromb Thrombolysis; 2007 Apr; 23(2):115-20. PubMed ID: 17131173 [TBL] [Abstract][Full Text] [Related]
2. Circulating soluble CR1 (CD35). Serum levels in diseases and evidence for its release by human leukocytes. Pascual M; Duchosal MA; Steiger G; Giostra E; Pechère A; Paccaud JP; Danielsson C; Schifferli JA J Immunol; 1993 Aug; 151(3):1702-11. PubMed ID: 8335953 [TBL] [Abstract][Full Text] [Related]
3. In-hospital and long-term prognostic value of fibrinogen, CRP, and IL-6 levels in patients with acute myocardial infarction treated with thrombolysis. Ziakas A; Gavrilidis S; Giannoglou G; Souliou E; Gemitzis K; Kalampalika D; Vayona MA; Pidonia I; Parharidis G; Louridas G Angiology; 2006; 57(3):283-93. PubMed ID: 16703188 [TBL] [Abstract][Full Text] [Related]
4. Soluble complement receptor type 1 (CD35) is released from leukocytes by surface cleavage. Danielsson C; Pascual M; French L; Steiger G; Schifferli JA Eur J Immunol; 1994 Nov; 24(11):2725-31. PubMed ID: 7957565 [TBL] [Abstract][Full Text] [Related]
5. Soluble complement receptor 1 is increased in patients with leukemia and after administration of granulocyte colony-stimulating factor. Sadallah S; Lach E; Schwarz S; Gratwohl A; Spertini O; Schifferli JA J Leukoc Biol; 1999 Jan; 65(1):94-101. PubMed ID: 9886251 [TBL] [Abstract][Full Text] [Related]
6. Complement Receptor 1 (CR1, CD35) Polymorphisms and Soluble CR1: A Proposed Anti-inflammatory Role to Quench the Fire of "Fogo Selvagem" Pemphigus Foliaceus. Oliveira LC; Kretzschmar GC; Dos Santos ACM; Camargo CM; Nisihara RM; Farias TDJ; Franke A; Wittig M; Schmidt E; Busch H; Petzl-Erler ML; Boldt ABW Front Immunol; 2019; 10():2585. PubMed ID: 31824479 [TBL] [Abstract][Full Text] [Related]
7. [Platelet activation in the early phases of acute myocardial infarction]. Salvioni A; Giraldi F; Assanelli E; Lauri G; Grazi M; Pardea S; Marenzi G Cardiologia; 1998 Aug; 43(8):825-32. PubMed ID: 9808873 [TBL] [Abstract][Full Text] [Related]
8. Anistreplase: a new thrombolytic for the treatment of acute myocardial infarction. Munger MA; Forrence EA Clin Pharm; 1990 Jul; 9(7):530-40. PubMed ID: 2198125 [TBL] [Abstract][Full Text] [Related]
9. Soluble complement receptor type 1 prevents human complement-mediated damage of the rabbit isolated heart. Homeister JW; Satoh PS; Kilgore KS; Lucchesi BR J Immunol; 1993 Feb; 150(3):1055-64. PubMed ID: 8423331 [TBL] [Abstract][Full Text] [Related]
10. Increased levels of plasma thrombomodulin in patients with acute myocardial infarction who had thrombolytic therapy and achieved successful reperfusion. Ileri M; Hisar I; Yetkin E; Koşar F; Cehreli S; Korkmaz S; Demirkan D Clin Cardiol; 2001 May; 24(5):377-9. PubMed ID: 11346245 [TBL] [Abstract][Full Text] [Related]
18. Relationship between initial white blood cell counts, stage of acute myocardial infarction evolution at presentation, and incidence of Thrombolysis In Myocardial Infarction-3 flow after streptokinase. Wong CK; French JK; Gao W; White HD Am Heart J; 2003 Jan; 145(1):95-102. PubMed ID: 12514660 [TBL] [Abstract][Full Text] [Related]
19. Increased left ventricular dysfunction in elderly patients despite successful thrombolysis: the GUSTO-I angiographic experience. Lesnefsky EJ; Lundergan CF; Hodgson JM; Nair R; Reiner JS; Greenhouse SW; Califf RM; Ross AM J Am Coll Cardiol; 1996 Aug; 28(2):331-7. PubMed ID: 8800106 [TBL] [Abstract][Full Text] [Related]